Why GLP-1s Are So Expensive: The Complex World of PBMs with Josh Sanders, PharmD

Send us Fan MailIn this episode, Ana Reisdorf speaks with Josh Sanders, the director of pharmacy at OnSiteRx, about the complexities of pharmacy benefits managers (PBMs) and their impact on drug pricing, particularly for GLP-1 medications like Ozempic, Mounjaro, or Zpebound. They discuss the role of PBMs in formulary management, the use of copay cards, the implications of compounding pharmacies, and the challenges posed by prior authorizations. The conversation also touches on the future of GLP-1 medications, concerns over their widespread use, and the importance of advocating for oneself in the healthcare system.About Josh:Josh Sanders, PharmD is a seasoned professional with over a decade of experience in optimizing pharmacy operations and delivering significant cost savings within complex healthcare environments. As the Director of Pharmacy at On-Site Rx, he leads strategic oversight for ten pharmacies across four states and advises large self-funded employers on benefits design. His expertise spans clinical guidance, operational efficiency, and navigating the evolving landscape of pharmaceutical care.About our sponsors:Visit Calocurb.com and use the code ANA10 for 10% offVisit Gruns.co and use the code GLP1HUB for 52% offVisit Hero.co and use the code GLP1HUB for 10% off📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com📷 Follow on Instagram: @glp1hub📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.